SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001017491-17-000104
Filing Date
2017-09-11
Accepted
2017-09-11 17:05:00
Documents
6
Period of Report
2017-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kseptember17financing.htm 8-K 56071
2 EXHIBIT 4.1 ex41formofwarrant.htm EX-4.1 102239
3 EXHIBIT 4.2 ex42formofregistrationrigh.htm EX-4.2 165795
4 EXHIBIT 10.1 ex101spa.htm EX-10.1 249518
5 EXHIBIT 10.2 ex102engagementletter.htm EX-10.2 58898
6 EXHIBIT 99.1 ex991pressrelease.htm EX-99.1 12496
  Complete submission text file 0001017491-17-000104.txt   646351
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 171079504
SIC: 2834 Pharmaceutical Preparations